C12N 2770/32621
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2770/32621 (Viruses as such) appears on 8 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 18
- Assignees
- 10
- Inventors
- 42
- Latest grant
- 24 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 2 | 0 |
| 2017 | 0 | 2 |
| 2018 | 2 | 1 |
| 2019 | 1 | 3 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof24 Oct 2023US 11,793,869 B2Serum Institute of India Pvt Ltd
- Attenuated viruses useful for vaccines2 Nov 2021US 11,162,080 B2The Research Foundation for The State University of New York
- Combination treatment18 Aug 2020US 10,744,170 B2Duke University
- Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strains26 Mar 2019US 10,238,730 B2Janssen Vaccines & Prevention B. V.
- Methods of making modified viral genomes17 Jul 2018US 10,023,845 B2The Research Foundation for The State University of New York
- Neoadjuvant cancer treatment31 Jul 2025US 2025/0241969 A1Duke University
- Combination Treatment19 Dec 2024US 2024/0415906 A1Duke University
- Attenuated viruses useful for vaccines11 Jul 2024US 2024/0228981 A1The Research Foundation for The State University of New York
- Recombinant enteroviruses and uses thereof27 Jul 2023US 2023/0233669 A1Aleph Therapeutics, Inc.
- Newcastle disease virus-based vectored vaccine22 Dec 2022US 2022/0402975 A1
Most cited
By later US patents
- Attenuated viruses useful for vaccines13US 9,476,032 B2The Research Foundation for The State University of New York · 2016
- Methods of making modified viral genomes2US 10,023,845 B2The Research Foundation for The State University of New York · 2018
- Attenuated viruses useful for vaccines1US 11,162,080 B2The Research Foundation for The State University of New York · 2021
- Immunogenic compositions comprising silicified virus and methods of use1US 9,993,543 B2Portland State University · 2018